http://www.dropbox.com/s/8w4l8iav9u4efjc/20171013_091337.mp4?dl=0Stem Cell Spinal Cord Injury Exoskeleton & Virtual Reality Study (SciExVR)

SciExVR is an innovative approach seeking to help patients with spinal cord injuries. The treatment consists of an injection of stem cells around the area of injury followed by stem cell treatment of the brain. Patients will be put through rehabilitation using an exoskeleton and virtual reality (VR) system in order to physically and mentally practice using limbs that had been formerly unusable.

SciExVR is for patients with spinal cord injuries at the thoracic, lumbar or sacral level with resultant paraplegia ( partial or complete) sensory or autonomic dysfunction (bowel, bladder, sexual). At this time cervical injuries and quadraplegia / tetraplegia are not eligible. The treatment consists of bone marrow derived stem cells provided in paired, paraspinal injections at, above and below the injury performed under radiologic guidance by our board certified, fellowship trained spinal surgeon. This is followed by intravenous and intranasal stem cells for additional treatment of brain, upper motor and sensory neurons.

Our initial patient, at the one month postop visit, showed improvement of 1 to 2 sensory levels on ASIA assessment and improvement in sphincter tone. At 2 months they reported internal sensory sensation of bowel activity and proprioception of knee and quadriceps movement. Improvement in certain mobility exercise was noted. Close to 3 months the patients stamina was reported improved with more exercise on the exoskeletal device noted and reduction in the assistance percent on the device.

The procedure is performed as an outpatient at the ParkCreek Surgery Center under general or MAC anesthesia by board certified anesthesiologists. Bone marrow aspiration is painless and performed by our board certified orthopedic surgeon. A 3 night stay is required in the area to allow a preop day, procedure day and postop visit. Patients may return home the postop day and flying is perfectly fine. Cost is USD $19,600.oo. Please see www.clinicaltrials.gov NCT 03225626.